Technical Analysis for EW - Edwards Lifesciences Corporation

Grade Last Price % Change Price Change
B 87.94 0.54% 0.47
EW closed up 0.54 percent on Thursday, May 13, 2021, on 42 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical EW trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Oversold Stochastic Weakness 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.54%
NR7 Range Contraction 0.54%
Down 3 Days in a Row Weakness 0.54%
Oversold Stochastic Weakness 0.54%
New Downtrend Bearish -1.75%
Older End-of-Day Signals for EW ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible Inside Day about 7 hours ago
Possible NR7 about 7 hours ago
60 Minute Opening Range Breakout about 10 hours ago
Up 1% about 10 hours ago
Down 2 % 1 day ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Edwards Lifesciences Corporation Description

Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. The company offers surgical heart valve therapy products, such as tissue heart valves and repair products, which are used to replace or repair a patient's diseased or defective heart valve; and produces pericardial and porcine valves. Its surgical heart valve therapy products include Carpentier-Edwards PERIMOUNT pericardial valve that comprise PERIMOUNT Magna Ease valves for aortic and mitral replacement; ThruPort systems that enable minimal incision valve surgery; and protection cannulae used during cardiac surgery in venous drainage, aortic perfusion, venting, and cardioplegia delivery. The company also provides transcatheter heart valves portfolio that includes technologies designed to treat heart valve disease using catheter-based approaches, as well as critical care products, such as hemodynamic monitoring systems to measure a patient's heart function in surgical and intensive care settings; Swan-Ganz line of pulmonary artery catheters and PreSep continuous venous oximetry catheters for measuring central venous oxygen saturation; VolumeView sensor-catheters; FloTrac continuous cardiac output monitoring system, a minimally invasive cardiac monitoring technology for goal-directed fluid optimization; and EV1000 clinical monitoring platform, which displays a patient's physiologic status. Its critical care products also include disposable pressure monitoring devices and closed blood sampling systems to help protect both patients and clinicians from the risk of infection; and products used to treat endolumenal occlusive disease, including balloon-tipped, catheter-based embolectomy products, surgical clips, and clamps. The company distributes its products through direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1999 and is headquartered in Irvine, California.


Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Clinical Medicine Surgery Catheter Infection Irvine Catheters Oxygen Drainage Artery Incision Perfusion Cardiac Surgery Repair Products Cannula Cardiac Monitoring Heart Disease Heart Valve Care Products Ricard Cardiac Output Edwards Embolectomy Heart Heart Valves Edwards Lifesciences Heart Valve Disease Valvular Heart Disease

Is EW a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 98.1
52 Week Low 66.23
Average Volume 2,520,187
200-Day Moving Average 83.96
50-Day Moving Average 86.76
20-Day Moving Average 92.79
10-Day Moving Average 91.45
Average True Range 1.90
ADX 29.25
+DI 23.49
-DI 30.93
Chandelier Exit (Long, 3 ATRs ) 92.40
Chandelier Exit (Short, 3 ATRs ) 91.84
Upper Bollinger Band 99.31
Lower Bollinger Band 86.26
Percent B (%b) 0.13
BandWidth 14.06
MACD Line 0.49
MACD Signal Line 1.65
MACD Histogram -1.1619
Fundamentals Value
Market Cap 54.81 Billion
Num Shares 623 Million
EPS 1.27
Price-to-Earnings (P/E) Ratio 69.52
Price-to-Sales 12.31
Price-to-Book 12.62
PEG Ratio 3.06
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 89.74
Resistance 3 (R3) 89.77 89.19 89.44
Resistance 2 (R2) 89.19 88.73 89.18 89.34
Resistance 1 (R1) 88.57 88.45 88.28 88.54 89.24
Pivot Point 87.99 87.99 87.85 87.98 87.99
Support 1 (S1) 87.37 87.53 87.08 87.34 86.64
Support 2 (S2) 86.79 87.25 86.78 86.54
Support 3 (S3) 86.17 86.79 86.44
Support 4 (S4) 86.14